What is the diagnostic work‑up for primary hyperparathyroidism in a 77‑year‑old patient?

Diagnostic Work-Up for Primary Hyperparathyroidism in a 77-Year-Old Patient

The diagnosis of primary hyperparathyroidism requires biochemical confirmation with repeated measurements of serum calcium and intact parathyroid hormone (PTH), followed by assessment for complications and surgical candidacy through specific laboratory tests and imaging studies. 1

Initial Biochemical Diagnosis

Measure serum calcium and intact PTH to establish the diagnosis. 1 In primary hyperparathyroidism, PTH is elevated or inappropriately normal in the setting of hypercalcemia. 1 Because calcium levels can fluctuate, repeat the measurement and correct for albumin levels by calculation, or measure ionized calcium directly. 2

• The biochemical hallmark is hypercalcemia with an elevated or inappropriately normal PTH concentration. 1
• For classic primary hyperparathyroidism, the specific PTH assay generation used (second vs. third generation) does not significantly affect diagnosis or management decisions. 3
• Use assay-specific reference values when interpreting PTH results. 3

Complete Laboratory Work-Up

Once biochemical diagnosis is confirmed, obtain the following tests to assess disease severity and complications: 2

• Serum creatinine/glomerular filtration rate (GFR) to evaluate renal function 2
• Serum phosphate (typically low in primary hyperparathyroidism) 2
• 25-OH vitamin D3 to identify deficiency that should be corrected before surgery 2
• 24-hour urine calcium to detect hypercalciuria (>400 mg/day is a surgical indication) 4
• Alkaline phosphatase as a marker of bone turnover 5

Assessment for Target Organ Complications

Evaluate for skeletal and renal complications that influence surgical decision-making: 4, 2

• Dual-energy X-ray absorptiometry (DXA) at lumbar spine, femoral neck, total femur, and distal forearm to determine bone mineral density 2
• Renal ultrasound to detect nephrocalcinosis or kidney stones 2

These studies identify complications that constitute surgical indications even in asymptomatic patients. 4

Clinical Assessment Specific to Elderly Patients

In this 77-year-old patient, carefully evaluate for symptoms that may be attributed to hyperparathyroidism: 6

• Neurologic and psychiatric disorders (fatigue, cognitive impairment, depression) are the most common presenting symptoms in elderly patients (present in approximately 60% of cases). 6
• Bone pain, muscle weakness, and fracture history 4
• History of kidney stones or renal insufficiency 4

The majority of elderly patients report improvement in neurologic symptoms, particularly fatigue and intellectual function, after successful parathyroidectomy. 6

Surgical Candidacy Criteria

Surgery is indicated if any of the following criteria are met: 4

• Serum calcium >1 mg/dL (0.25 mmol/L) above the upper limit of normal 4
• Marked hypercalciuria (>400 mg/day) 4
• Low bone mineral density (T-score ≤ -2.5 at any site) 4
• Creatinine clearance <60 mL/min 4
• Age <50 years (not applicable to this patient) 4
• Episode of acute primary hyperparathyroidism 4
• Vitamin D deficiency (should prompt consideration of surgery after repletion) 4

In elderly patients, surgery should be strongly considered even at age 77, as studies demonstrate a 3.8% mortality rate with modern surgical techniques and 94% cure rates, with marked improvement in quality of life. 6

Preoperative Localization Studies

Imaging should only be performed if surgery is planned. 2 Imaging has no utility in confirming or excluding the diagnosis of primary hyperparathyroidism. 1

The standard approach combines: 2

• Neck ultrasound as the initial study 2
• 99mTc-sestamibi (MIBI) scintigraphy for functional localization 2

These two modalities together typically provide sufficient localization for surgical planning. 2 In elderly or fragile patients, accurate preoperative localization is particularly important to facilitate minimally invasive parathyroidectomy. 4

Important Caveats for This Age Group

Age alone should not preclude surgical treatment. 6 Studies of patients >75 years demonstrate:

• Postoperative mortality of 3.8% (with no deaths since 1984 in one series) 6
• Significant complication rate of only 4% 6
• Average hospital stay of 4 days 6
• 94% of patients report symptom improvement, especially in fatigue and cognitive function 6

However, surveillance without surgery may be appropriate for: 7

• Patients with borderline calcium elevation (≤2.7 mmol/L) 7
• Absence of symptoms or complications known to benefit from surgery 7
• Significant medical comorbidities that substantially increase surgical risk 4

If surveillance is chosen, monitor with: 4

• Biannual serum calcium measurements 4
• Annual urinary calcium excretion 4
• Annual bone mineral density measurements 4

Higher age at diagnosis is associated with increased risk of coexistent hypertension and fractures, making thorough evaluation particularly important in this population. 5